Biopol Chemicals’ SME IPO also opened on 6 February 2026, with a goal to raise ₹31.26 crore via fresh equity. The offer will stay open until 10 February 2026, with listing planned on the NSE SME platform on 13 February 2026. Early grey market premium stands near 0%, indicating lukewarm unlisted market expectations for grey market listing gains.
What’s next:
Subscription trends from retail and high-net-worth segments will be key in determining whether the issue draws broader participation before its SME listing.
